TIC ACUREN CORP

AMEX www.acuren.com


$ 9.77 $ -0.50 (-4.86 %)    

Friday, 14-Nov-2025 15:55:02 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 9.78
$ 9.78
$ 9.78 x 313
$ 9.78 x 668
$ 9.69 - $ 10.10
$ 8.76 - $ 14.94
4,895,522
na
1.21B
$ 0.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

UBS analyst Joshua Chan maintains TIC Solutions (NYSE:TIC) with a Neutral and lowers the price target from $15 to $11.5.

Core News & Articles

TIC Solutions (NYSE:TIC) affirms FY2025 sales outlook from $1.530 billion-$1.565 billion to $1.530 billion-$1.565 billion vs $1...

Core News & Articles

Acuren (NYSE:TIC) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $0.04 by 316.22...

Core News & Articles

Baird analyst Andrew Wittmann initiates coverage on Acuren (NYSE:TIC) with a Neutral rating and announces Price Target of $15.

Core News & Articles

UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and raises the price target from $11 to $15.

Core News & Articles

Acuren (NYSE:TIC) sees FY2025 sales of $1.530 billion-$1.565 billion vs $1.139 billion analyst estimate.

Core News & Articles

Acuren (NYSE:TIC) sees Q3 sales of $460.000 million-$480.000 million vs $483.005 million analyst estimate.

Core News & Articles

Jefferies analyst Stephanie Moore initiates coverage on Acuren (NYSE:TIC) with a Buy rating and announces Price Target of $16.

Core News & Articles

Acuren (NYSE:TIC) reported quarterly sales of $313.925 million which beat the analyst consensus estimate of $308.405 million by...

Core News & Articles

UBS analyst Joshua Chan maintains Acuren (NYSE:TIC) with a Neutral and lowers the price target from $11.5 to $11.

Core News & Articles

Acuren Corporation (NYSE:TIC) ("Acuren") today announced the expiration of the 60-day "go-shop" period ("Go...

Core News & Articles

Acuren Corporation (NYSE:TIC) (the "Company" or "Acuren"), a leading provider of critical asset integrity servi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION